Body by Kotoske

NEW YORK, June 9, 2022 /PRNewswire/ -- The Global Breast Imaging Market is expected to clock US$ ~ 8.46 billion by 2031 owing to the rising prevalence of breast cancer, growing awareness of early diagnosis, and the rising new product launches by players in the market. According to the latest report published by Growth Plus Reports, titled "Breast Imaging Market by Technology (Ionizing Technology and Non-Ionizing Technology), Materials (Hospitals & Clinics and Diagnostics Center)–Global Outlook & Forecast 2021-2031 "The Breast Imaging market was worth ~US$ 2.76 billion in 2020 and is expected to grow at a CAGR of 10.7% during the forecast period, 2021-2031 Get a sample PDF of this research report: Growth Engines Breast cancer is the second leading cause of death in women globally. The rising incidence of breast cancer, the rising awareness of early detection of breast cancer, and rising investments in the development of new imaging systems are some of the factors propelling the market growth. Companies in the market are focused on adopting various organic as well as inorganic strategies. For instance, in February 2021, SmartBreast Corporation formed a partnership with FoxSemicon Integrated Technologies, Inc. to manufacture molecular breast imaging (MBI) systems. FoxSemicon has invested in SmartBreast Corporation and will contract manufacturer two MBI systems acquired by SmartBreast i.e. the GE Healthcare Discovery NM 750b and the Dilon Technologies D6800. Such strategic partnerships or collaborations help the company to strengthen their foothold in the market. The global breast imaging market has been analyzed from three perspectives: Technology, End User, and Region. Restraints However, complications related to breast implants are expected to restrain the market growth to a certain extent. Common complications associated with breast implants include infection, chronic breast pain, rupturing or leaking of the implant, necrosis, and breast or nipple numbness. Furthermore, among the patients who had undergone reconstruction surgery, around 45% of patients with silicone gel implants and around 20% with saline implants underwent at least one additional operation within 3 years. Whereas, around 25% of patients with silicone implants and 8% of patients with saline implants removed their implants. Therefore, complications associated with implants and an increase in the overall cost due to these complications are expected to limit the growth of the market. Excerpts from 'By Technology Segmentation' Based on technology, the breast imaging market has been segmented into :- Ionizing Technology Non-Ionizing Technology The Ionizing technology segment is further bifurcated into mammography, molecular breast imaging (MBI), positron emission tomography-computed tomography (PET-CT), positron emission mammography (PEM), and cone-beam computed tomography (CBCT). The mammography segment is further sub-segmented into 3D breast tomosynthesis, analog mammography, and full-field digital mammography (FFDM). The non-ionizing technology segment is further categorized as breast MRI, breast ultrasound, automated whole-breast ultrasound (AWBU), breast thermography, optical imaging, and electric impedance tomography. The non-ionizing breast imaging segment is anticipated to grow at the highest CAGR during the projected period. The advantages offered by these imaging technologies compared to ionizing breast imaging systems such as higher sensitivity, relatively low cost, and easy accessibility are some of the factors that are expected to increase the adoption of these systems in the coming years. Moreover, technological advancements and new product launches are fueling the growth of this segment. Ask here for more customization [email protected] Excerpts from 'By Region Segmentation' Regionally, the global breast imaging market has been segmented into North America Europe Asia Pacific The Rest of the World (RoW). North America held the largest share of the global breast imaging market in 2020. The growing old age population, the rising incidence of breast cancer, and higher awareness among the population regarding early diagnosis of breast cancer are some of the factors driving the market growth in this region. Moreover, a favorable reimbursement scenario for breast imaging is further boosting the breast imaging market growth in this region. Excerpts from 'Competitive Landscape' Some of the prominent players operating in the global breast imaging market include: - General Electric Company Hologic, Inc Siemens Healthcare Koninklijke Philips N.V Fujifilm Corporation Planmed OY Canon Medical Systems Dilon Medical Technologies, Inc Aurora Healthcare US Corp Delphinus Medical Technologies, Inc Among others Table Of Contents 1 INTRODUCTION 1.1 Market Ecosystem 1.2 Geographic Scope 1.3 Timeline Under Consideration • Historical Years – 2018 & 2019 • Base Year – 2020 • Forecasted Years – 2021 to 2031 1.4 Currency Used in the Report 2 RESEARCH METHODOLOGY 2.1 Research Approach 2.2 Data Collection Methodology 2.3 Data Sources 2.3.1 Secondary Sources 2.3.2 Primary Sources 2.4 Market Estimation Approach 2.4.1 Bottom Up 2.4.2 Top Down 2.5 Market Forecasting Model 2.6 Limitations and Assumptions 3 PREMIUM INSIGHTS 3.1 Current Market Trend (COVID-19 Perspective) 3.2 Key Players & Their Competitive Positioning (2020) 4 MARKET DYNAMICS 4.1 Drivers 4.2 Restraints/Challenges 4.3 Opportunities 5 GLOBAL BREAST IMPLANTS MARKET - ANALYSIS & FORECAST, BY IMPLANT TYPE 5.1 Silicone Implant 5.2 Saline Implant 6 GLOBAL BREAST IMPLANTS MARKET - ANALYSIS & FORECAST, BY APPLICATION 6.1 Breast Reconstruction 6.2 Breast Augmentation 7 GLOBAL BREAST IMPLANTS MARKET - ANALYSIS & FORECAST, BY END USER 7.1 Hospitals 7.2 Cosmetology Clinics 7.3 Others (Ambulatory Care Center, Etc.) TOC Continued… VALUE PROPOSITIONS RELATED TO THE REPORT: Powered with Complimentary Analyst Hours and Expert Interviews with Each Report Comprehensive quantitative and qualitative insights at segment and sub-segment level Covid 19 impact trends and perspective Granular insights at global/regional/country level Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment Blanket coverage on competitive landscape Winning imperatives Exhaustive coverage on 'Strategic Developments' registered by leading players of the market CUSTOMIZATION OPTIONS: Distributor Landscape Assessment Pricing Intelligence Customer Base Assessment Investment & Initiatives Analysis 'Business Profile' of Key Players Buy this Premium Research Report at About Us: Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020. Contact: Manan Sethi Director, Market Insights Email: [email protected] Phone no: +91 96545 76783 Web: Follow Us: LinkedIn | Twitter SOURCE Growth Plus Reports

DUBLIN, June 3, 2022 /PRNewswire/ -- The "Cosmetic Surgery And Procedure Market Size, Share & Trends Analysis Report by Type (Invasive, Non-invasive), Region (North America, Asia Pacific, Middle East & Africa, Latin America, Europe), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering. The global cosmetic surgery and procedure market size is expected to reach USD 145.7 billion by 2030, registering a CAGR of 9.6%. Technological developments, growing use of social media, and increasing disposable income are some of the factors likely to drive the market during the forecast period. The substantial increase in the volume of cosmetic procedures can be attributed to the popularity of digital photography, rising demand by consumers to boost self-esteem, the introduction of self-monitoring apps, and the increasing affordability of cosmetic surgeries in developing countries. Furthermore, risk associated with cosmetic surgery has decreased due to technological developments and the presence of skilled surgeons. It was observed that the volume of both surgical and nonsurgical cosmetic procedures has increased in the past few years. This can be attributed to increasing disposable income, increasing safety of surgical procedures, growing faith of patients on such surgeries, and growing medical tourism. Cosmetic Surgery And Procedure Market Report Highlights The rising volume of cosmetic surgeries due to increasing demand from emerging countries is expected to boost the market. The cosmetic surgery or surgical procedure segment accounted for the maximum share in 2016 due to increasing affordability of cosmetic procedures, increasing the safety of surgeries, the growing reliance of patients on surgeries to achieve positive outcomes, the presence of skilled surgeons, and long-lasting results. The non-surgical cosmetic procedure segment is likely to witness the fastest growth in the coming years due to higher awareness and lower risk in comparison to surgical procedures. Furthermore, nonsurgical procedures are more economical and a large number of relevant service providers are easily available. Geographically, North America dominated the cosmetic surgery and procedure market in 2016. It is anticipated to maintain its dominant position during the forecast period due to increased awareness about aesthetic procedures, higher healthcare expenditure as compared to other developing countries, and greater adoption of procedures by both men and women.. The cosmetic surgery and procedure industry in Asia Pacific is expected to witness the fastest growth over the next decade owing to the growing medical tourism, improving healthcare infrastructure, and availability of high-quality services.. People from developed countries travel to India, Brazil, Mexico, Malaysia, and South Korea for affordable cosmetic procedures. Hence, the market is expected to witness strong growth in developing countries. Some of the key players operating in the market are ALLERGAN; Merz Pharma; Nestle; Cutera; Cynosure, Inc.; Ipsen; Sientra, Inc.; Alma Lasers; and Johnson & Johnson. Key Topics Covered: Chapter 1. Methodology and Scope Chapter 2. Executive Summary Chapter 3. Cosmetic Surgery & Procedure Market Variables, Trends & Scope 3.1. Market Lineage outlook 3.1.1. Parent market outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Market Dynamics 3.3.1. Market Driver Analysis 3.3.1.1. Increasing adoption of minimally invasive treatments 3.3.1.2. Growing population aged between 25 and 65 years 3.3.2. Market Restraint Analysis 3.3.2.1. Lack of reimbursement coverage 3.3.2.2. Stringent regulatory framework 3.4. Cosmetic Surgery & Procedure: Market Analysis Tools 3.4.1. Industry Analysis-Porter's 3.4.2. PESTEL Analysis 3.4.3. Major Deals & Strategic Alliances Analysis Chapter 4. Cosmetic Surgery & Procedure Market: Segment Analysis, By -Procedure Type, 2018-2030 (USD Million) 4.1. Definitions & Scope 4.2. Procedure type market share analysis, 2021 & 2030 4.3. Global Cosmetic Surgery & Procedure Market, By Procedure Type, 2017 to 2030 4.4. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following 4.4.1. Invasive procedures 4.4.1.1. Breast Augmentation 4.4.1.2. Liposuction 4.4.1.3. Nose Reshaping 4.4.1.4. Eyelid Surgery 4.4.1.5. Tummy Tuck 4.4.1.6. Others 4.4.2. Non-invasive Procedure 4.4.2.1. Botox Injections 4.4.2.2. Soft Tissue Fillers 4.4.2.3. Chemical Peel 4.4.2.4. Laser Hair Removal 4.4.2.5. Microdermabrasion 4.4.2.6. Others Chapter 5. Cosmetic Surgery & Procedure Market: Regional Market Analysis, By Region, 2018-2030 (USD Million) Chapter 6. Cosmetic Surgery & Procedure Market-Competitive Analysis 6.1. Company/Competition Categorization (Key innovators, Market leaders, Emerging players) 6.2. Vendor Landscape 6.2.1. List of key distributors and channel partners 6.3. Key companies profiled 6.3.1. Evolus, Inc. 6.3.1.1. Company Overview 6.3.1.2. Financial Performance 6.3.1.3. Product Benchmarking 6.3.1.4. Strategic Initiatives 6.3.2. Cynosure. 6.3.2.1. Company Overview 6.3.2.2. Financial Performance 6.3.2.3. Product Benchmarking 6.3.2.4. Strategic Initiatives 6.3.3. Revance Therapeutics, Inc. 6.3.3.1. Company Overview 6.3.3.2. Financial Performance 6.3.3.3. Product Benchmarking 6.3.3.4. Strategic Initiatives 6.3.4. Galderma S.A. 6.3.4.1. Company Overview 6.3.4.2. Financial Performance 6.3.4.3. Product Benchmarking 6.3.4.4. Strategic Initiatives 6.3.5. Alma Lasers 6.3.5.1. Company Overview 6.3.5.2. Financial Performance 6.3.5.3. Product Benchmarking 6.3.5.4. Strategic Initiatives 6.3.6. AbbVie 6.3.6.1. Company Overview 6.3.6.2. Financial Performance 6.3.6.3. Product Benchmarking 6.3.6.4. Strategic Initiatives 6.3.7. Solta Medical 6.3.7.1. Company Overview 6.3.7.2. Financial Performance 6.3.7.3. Product Benchmarking 6.3.7.4. Strategic Initiatives 6.3.8. Lumenis 6.3.8.1. Company Overview 6.3.8.2. Financial Performance 6.3.8.3. Product Benchmarking 6.3.8.4. Strategic Initiatives 6.3.9. Syneron Candela 6.3.9.1. Company Overview 6.3.9.2. Financial Performance 6.3.9.3. Product Benchmarking 6.3.9.4. Strategic Initiatives For more information about this report visit Media Contact: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets